메뉴 건너뛰기




Volumn 109, Issue 6, 2007, Pages 1456-1457

Nuchal translucency and the risk of congenital heart disease [5]

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CONGENITAL HEART DISEASE; CYSTIC LYMPHANGIOMA; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; LETTER; NEWBORN MORBIDITY; NUCHAL TRANSLUCENCY MEASUREMENT; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL;

EID: 34249901287     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000267188.20278.b0     Document Type: Letter
Times cited : (6)

References (8)
  • 3
    • 0033537299 scopus 로고    scopus 로고
    • Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study
    • Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999;318:81-5.
    • (1999) BMJ , vol.318 , pp. 81-85
    • Hyett, J.1    Perdu, M.2    Sharland, G.3    Snijders, R.4    Nicolaides, K.H.5
  • 4
    • 0035086937 scopus 로고    scopus 로고
    • Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses
    • Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001;17:102-5.
    • (2001) Ultrasound Obstet Gynecol , vol.17 , pp. 102-105
    • Michailidis, G.D.1    Economides, D.L.2
  • 5
    • 33747884828 scopus 로고    scopus 로고
    • Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
    • Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL, et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol 2006;195:843-7.
    • (2006) Am J Obstet Gynecol , vol.195 , pp. 843-847
    • Comstock, C.H.1    Malone, F.D.2    Ball, R.H.3    Nyberg, D.A.4    Saade, G.R.5    Berkowitz, R.L.6
  • 6
    • 11144248419 scopus 로고    scopus 로고
    • Counselling following a diagnosis of congenital heart disease
    • Allan LD, Huggon IC. Counselling following a diagnosis of congenital heart disease. Prenat Diagn 2004;24:1136-42.
    • (2004) Prenat Diagn , vol.24 , pp. 1136-1142
    • Allan, L.D.1    Huggon, I.C.2
  • 7
    • 0034987376 scopus 로고    scopus 로고
    • Isolated major congenital heart disease
    • Campbell S. Isolated major congenital heart disease. Ultrasound Obstet Gynecol 2001;17:370-9.
    • (2001) Ultrasound Obstet Gynecol , vol.17 , pp. 370-379
    • Campbell, S.1
  • 8
    • 23644436270 scopus 로고    scopus 로고
    • Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype
    • Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005;26:154-7.
    • (2005) Ultrasound Obstet Gynecol , vol.26 , pp. 154-157
    • Atzei, A.1    Gajewska, K.2    Huggon, I.C.3    Allan, L.4    Nicolaides, K.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.